Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human COLEC12 ELISA Kit (AC2509)
Cat.#: ASET-1098
Specifications
Description Human COLEC12 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human COLEC12 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.043 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2175 Human NKCC1 ELISA Kit (AC3586) Quantitative inquiry ASET-1123 Rat Calbindin ELISA Kit (AC2534) Quantitative inquiry ASET-1636 Mouse Insulin Receptor beta ELISA Kit (AC3047) Quantitative inquiry ASET-2489 Rat EAAT1 ELISA Kit (AC3900) Quantitative inquiry ASET-1109 Human SNPH ELISA Kit (AC2520) Quantitative inquiry ASET-2316 Rat IL-6 ELISA Kit (AC3727) Quantitative inquiry ASET-1576 Mouse CHRDL1 ELISA Kit (AC2987) Quantitative inquiry ASET-1889 Human Toca-1 ELISA Kit (AC3300) Quantitative inquiry ASET-1685 Human Ephrin B1 ELISA Kit (AC3096) Quantitative inquiry ASET-2227 Human PON2 ELISA Kit (AC3638) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket